- Home
- DTE vs WAT Comparison
DTE vs WAT Comparison
Compare DTE & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTE
- WAT
- Stock Information
- Founded
- DTE 1903
- WAT 1958
- Country
- DTE United States
- WAT United States
- Employees
- DTE N/A
- WAT N/A
- Industry
- DTE Electric Utilities: Central
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- DTE Utilities
- WAT Industrials
- Exchange
- DTE Nasdaq
- WAT Nasdaq
- Market Cap
- DTE 29.0B
- WAT 17.8B
- IPO Year
- DTE N/A
- WAT 1995
- Fundamental
- Price
- DTE $136.06
- WAT $296.53
- Analyst Decision
- DTE Buy
- WAT Hold
- Analyst Count
- DTE 12
- WAT 14
- Target Price
- DTE $144.27
- WAT $374.07
- AVG Volume (30 Days)
- DTE 948.3K
- WAT 586.5K
- Earning Date
- DTE 10-23-2025
- WAT 10-31-2025
- Dividend Yield
- DTE 3.19%
- WAT N/A
- EPS Growth
- DTE 3.66
- WAT 10.77
- EPS
- DTE 6.93
- WAT 11.09
- Revenue
- DTE $14,201,000,000.00
- WAT $3,046,056,000.00
- Revenue This Year
- DTE $10.21
- WAT $7.19
- Revenue Next Year
- DTE $4.15
- WAT $6.40
- P/E Ratio
- DTE $19.74
- WAT $26.65
- Revenue Growth
- DTE 14.55
- WAT 5.89
- 52 Week Low
- DTE $115.59
- WAT $275.05
- 52 Week High
- DTE $142.05
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- DTE 45.35
- WAT 48.69
- Support Level
- DTE $134.12
- WAT $294.96
- Resistance Level
- DTE $137.29
- WAT $303.24
- Average True Range (ATR)
- DTE 1.37
- WAT 8.73
- MACD
- DTE -0.13
- WAT 0.36
- Stochastic Oscillator
- DTE 41.52
- WAT 42.13
About DTE DTE Energy Company
DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.